NYU cancer center

New York, New York 10016

1 studies enrolling now · 16 studies all time

What they study most

Atypical Endometrial Hyperplasia, B-cell Malignancies, Breast Cancer, Colorectal Cancer (CRC), Endometrial Carcinoma, Esophageal Cancer, Gastric Adenocarcinoma, Gastric Cancer, Glioblastoma, Head and Neck Cancer, Lung Cancer, Lymphedema

Studies at this site

• A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation — Recruiting now
• A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer — Stopped early
• A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) — Completed
• Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer — Completed
• A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma — Completed
• Cancer Screening and Prevention Program for High Risk Women — Completed
• Exemestane and Cyclophosphamide for Metastatic Breast Cancer — Completed
• Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer — Completed
• Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate — Completed
• Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration — Completed
• Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers — Stopped early
• Combination of Revlimid, Melphalan and Dexamethasone as First Line Treatment for Multiple Myeloma — Stopped early
• Enhancing Management of Chronic Pain and Symptoms Among Women Treated for Breast Cancer (Lymph-Flow) — Completed
• Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer — Completed
• Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer — Completed
• Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian Origin — Stopped early